Experimental HIV vaccine induces key antibodies in nearly half of tested primates

An experimental HIV vaccine has demonstrated encouraging results by successfully inducing broadly neutralizing antibodies in 44% of primates involved in trials. This development marks a notable advancement in the ongoing global effort to create an effective vaccine against HIV. The findings represent a significant step towards potential human trials and future prevention strategies.